Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: Comparison with intracavernosal injection of vasoactive agents - Initial experience

Radiology

Volumn 237, Issue 3, 2005, Pages 986-991

  Copel, Laurian ^a   Katz, Ran ^b   Blachar, Arye ^a   Sosna, Jacob ^b,c   Sheiman, Robert G ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; SILDENAFIL; VASOACTIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CORPUS CAVERNOSUM; DOPPLER ECHOGRAPHY; ECHOGRAPHY; ERECTILE DYSFUNCTION; HEMODYNAMIC MONITORING; HUMAN; INTERMETHOD COMPARISON; MALE; PENIS ARTERY; PENIS ERECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEXUAL AROUSAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; ALPROSTADIL; HUMANS; IMPOTENCE, VASCULOGENIC; INJECTIONS; MALE; MIDDLE AGED; PAPAVERINE; PENILE ERECTION; PENIS; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 27744491635     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2373041529     Document Type: Article

References (29)

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90.
2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151:54-61.
3. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338:1397-1404.
4. Jarow JP, Burnett AL, Geringer AM. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol 1999;162:722-725.
5. Meuleman E, Cuzin B, Opsomer RJ, et al. A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction. BJU Int 2001;87:75-81.
6. Virag R, Shoukry K, Floresco J, et al. Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. J Urol 1991;145:287-292.
7. Montorsi F, Guazzoni G, Bergamaschi F, et al. Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. Urology 1993;42:554-558.
8. Heaton JP, Lording D, Liu SN, et al. Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men. Int J Impot Res 2001;13:317-321.
9. Quam JP, King BF, James EM, et al. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. AJR Am J Roentgenol 1989;153:1141-1147.
10. Schwartz AN, Wang KY, Mack LA, et al. Evaluation of normal erectile function with color flow Doppler sonography. AJR Am J Roentgenol 1989;153:1155-1160.
11. Benson CB, Vickers MA. Sexual impotence caused by vascular disease: diagnosis with duplex sonography. AJR Am J Roentgenol 1989;153:1149-1153.
12. Benson CB, Aruny JE, Vickers MA Jr. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. AJR Am J Roentgenol 1993;160: 71-73.
13. Langtry HD, Markham A. Sildenafil: a review of its use in erectile dysfunction. Drugs 1999;57:967-989.
14. Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47-52.
15. Moreland RB, Goldstein I, Traish A. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells. Life Sci 1998;62: PL309-318.
16. Rajfer J, Aronson WJ, Bush PA, et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992;326:90-94.
17. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995;75:191-236.
18. Lue TF, Hricak H, Manch KW, et al. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology 1985;155:777-781.
19. King BF Jr. The penis. In: Rumack CM, Wilson SR, Charboneau JW. Diagnostic ultrasound, 2nd ed. St Louis, Mo: Mosby, 1998; 827-842.
20. Lim PH, Li MK, Ng FC, et al. Clinical efficacy and safety of sildenafil citrate (Viagra) in a multi-racial population in Singapore: a retrospective study of 1520 patients. Int J Urol 2002;9:308-315.
21. Basar M, Tekdogan UY, Yilmaz E, et al. The efficacy of sildenafil in different etiologies of erectile dysfunction. Int Urol Nephrol 2001;32:403-407.
22. Bacar MM, Batislam E, Altinok D, et al. Sildenafil citrate for penile hemodynamic determination: an alternative to intracavernosal agents in Doppler ultrasound evaluation of erectile dysfunction. Urology 2001;57:623-627.
23. Arslan D, Esen AA, Secil M, et al. A new method for the evaluation of erectile dysfunction: sildenafil plus Doppler ultrasonography. J Urol 2001;166:181-184.
24. Erdogru T, Usta MF, Ceken K, et al. Is sildenafil citrate an alternative agent in the evaluation of penile vascular system with color Doppler ultrasound? Urol Int 2002; 68:255-260.
25. Shabsigh R, Padma-Nathan H, Gittleman M, et al. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology 2000; 55:477-480.
26. McMahon CG, Samali R, Johnson H. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol 2000;164:1192-1196.
27. Bennett AH, Carpenter AJ, Barada JH. An improved vasoactive drug combination for a pharmacological erection program. J Urol 1991;146:1564-1565.
28. Bechara A, Casabe A, Cheliz G, et al. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses. J Urol 1996;155:913-914.
29. Meuleman EJ, Diemont WL. Investigation of erectile dysfunction: diagnostic testing for vascular factors in erectile dysfunction. Urol Clin North Am 1995;22:803-819.